14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 0HTC.L
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Cara Therapeutics, Inc. as stock downgraded to Strong Sell Candidate.
(Updated on Jun 19, 2024)

Sell candidate since Jun 19, 2024 PDF

No changes to the price of Cara Therapeutics, Inc. stock on the last trading day (Wednesday, 19th Jun 2024). During the last trading day the stock fluctuated 0% from a day low at $0.256 to a day high of $0.256. The price has fallen in 5 of the last 10 days and is down by -60.24% for this period.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.250 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -32.73% during the next 3 months and, with a 90% probability hold a price between $0.168 and $0.486 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

0HTC.L Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 18, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cara Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.445 and $0.669. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Cara Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 9.13%

Cara Therapeutics, Inc. is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (0HTC.L) For The Upcoming Trading Day Of Thursday 20th

For the upcoming trading day on Thursday, 20th we expect Cara Therapeutics, Inc. to open at $0.256, and during the day (based on 14 day Average True Range), to move between $0.191 and $0.321, which gives a possible trading interval of +/-$0.0655 (+/-25.57%) up or down from last closing price. If Cara Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 51.15% move between the lowest and the highest trading price during the day.

Is Cara Therapeutics, Inc. stock A Buy?

Cara Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Strong Sell candidate.

Current score: -5.167 Strong Sell Candidate Downgraded

Predicted Opening Price for Cara Therapeutics, Inc. of Thursday, June 20, 2024

Fair opening price June 20, 2024 Current price
$0.256 ( 0%) $0.256

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 0HTC.L

Fibonacci Support & Resistance Levels

Level Price
R3 0.256 -
R2 0.256 -
R1 0.256 -
Price 0.256
S1 0.256 -
S2 0.256 -
S3 0.256 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.256
S1 0 -
S2 0 -
S3 0 -

0HTC Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 15, 2022 Mar 15, 2022 Mar 15, 2022 $0.285 2.44%

FAQ

What is the symbol for Cara Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Cara Therapeutics, Inc. is 0HTC.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell Cara Therapeutics, Inc. Stock?
Cara Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Strong Sell candidate.

How to buy Cara Therapeutics, Inc. Stock?
Cara Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cara Therapeutics, Inc. Stock.

What's the current price of Cara Therapeutics, Inc. Stock?
As of the end of day on the Jun 19, 2024, the price of an Cara Therapeutics, Inc. (0HTC.L) share was $0.256.

What is the 52-week high and low for Cara Therapeutics, Inc. Stock?
The 52-week high for Cara Therapeutics, Inc. Stock is $4.45 and the 52-week low is $0.256.

What is the market capitalization of Cara Therapeutics, Inc. Stock?
As of the Jun 19, 2024, the market capitalization of Cara Therapeutics, Inc. is 14.15M.

When is the next earnings date for Cara Therapeutics, Inc.?
The upcoming earnings date for Cara Therapeutics, Inc. is Aug 05, 2024.
Click to get the best stock tips daily for free!